To explore the mechanism underlying improved hepatic steatosis and glycemic traits in Slc39a5-/- mice we evaluated two key signaling hubs that mediate lipid metabolism and insulin sensitivity, AMPK and AKT. This evidence concerns the gene INS and fatty liver disease.